PrognomIQ

PrognomiQ Is Enabling Early Disease Detection And Treatment

San Mateo, United States · Founded 2020 · $135.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$135.0M
Last Round
$34.0M Series CNov 2024
Rounds
3

About

PrognomiQ is a diagnostics company developing multi-omic blood tests for early detection and treatment of cancer and other complex diseases. By combining proprietary proteomics data at unprecedented scale with genomic and metabolomic data, the company builds transformative liquid biopsy products, including Provue Lung for early-stage lung cancer identification.

Summary

PrognomIQ is a Biotech company based in San Mateo, United States, founded in 2020. It has raised $135.0M in total across 3 rounds, most recently a $34.0M Series C round in Nov 2024. Investors include Seer Inc, Wing VC and Maverick Ventures.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CNov 2024
$34.0M

Sign up to see all 3 rounds

Series B through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PrognomIQ on Indexed.vc
<a href="https://indexed.vc/companies/prognomiq"><img src="https://indexed.vc/api/badge/company/prognomiq" alt="PrognomIQ on Indexed.vc" width="260" height="76" /></a>